Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to investigate the effects of metformin in addition to the conventional progestin therapy in the fertility-sparing treatment of early stage endometrial cancer.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04792749
Study type Interventional
Source Samsung Medical Center
Contact Joseph Noh, M.D.
Phone +82-10-9756-3249
Email joseph.noh@samsung.com
Status Recruiting
Phase Phase 3
Start date June 1, 2021
Completion date March 31, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04046185 - Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer Early Phase 1
Active, not recruiting NCT03469674 - PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer Phase 3
Not yet recruiting NCT06278857 - SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr) Phase 2
Completed NCT04972682 - [SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer N/A
Recruiting NCT05179447 - PROfiling Based Endometrial Cancer Adjuvant Therapy N/A
Recruiting NCT04073706 - Sentinel Node Biopsy in Endometrial Cancer Phase 3
Recruiting NCT04291612 - Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Recruiting NCT06417736 - Prospective Study for Endometrial Carcinoma and Hyperplasia in Childbearing-age Women N/A
Recruiting NCT04839614 - Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia N/A
Completed NCT03580421 - Cost-utility of Ambulatory Surgery in the Management of Endometrial Cancer(AMBU-ENDO) N/A